Active Ingredient(s):Romosozumab-aqqg FDA Approved: * April 9, 2019 Pharm Company: *AMGEN INC Category:Osteoporosis
Romosozumab, sold under the brand name Evenity, is a medication used to treat osteoporosis. It has been found to decrease the risk of fractures of the spine.
Common side effect include headache, joint pain, and pain at the site of injection. It may increase the risk of heart attacks, strokes, and deaths from cardiovascular disease. It is a humanized monoclonal antibody that targets sclerostin. Rese...
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion